Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 5

Lung Cancer Management in COVID-19 Pandemic

Pages
340–344
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is recommended that patients stay in their homes and not visit the hospital.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In studies published in China, lung cancer patients were identified as the greatest risk group during the COVID-19 pandemic due to their diseases and immunosuppressive treatments.
📊
Key Findings & Data:Poor prognosis is anticipated if COVID-19 pneumonia is detected in lung cancer patients.
💡
Conclusion & Impact:It is recommended that patients stay in their homes and not visit the hospital.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

In studies published in China, lung cancer patients were identified as the greatest risk group during the COVID-19 pandemic due to their diseases and immunosuppressive treatments. Poor prognosis is anticipated if COVID-19 pneumonia is detected in lung cancer patients. Oncology associations and specialists from countries such as China and Italy have published suggestions that allow patients to experience the pandemic with minimal harm. It is recommended that patients stay in their homes and not visit the hospital. This may mean postponing treatments, switching to oral form of treatments that must continue, and extending the intervals between IV treatments or reducing the number of cycles. When surgery is required, neoadjuvant chemotherapies are preferred. It is difficult to differentiate the symptoms or radiological images of the lung cancer patient with COVID 19 pneumonia vs cancer progression or treatment-related complications. Therefore, careful examination is key. In this article, we have compiled recommendations for the management of lung cancer during the COVID 19 pandemic.

🔖

Cite This Article

ŞİMŞEK, G. Ö. (2020). Lung Cancer Management in COVID-19 Pandemic. Turkish Thoracic Journal, Cilt: 21 - Sayı: 5, 340–344. https://ajindex.com/articles/417954

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. GLOBOCAN. Available from: 1. https://gco.iarc.fr/today/data/ factsheets/cancers/15-Lung-fact-sheet.pdf
  2. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England) 2020;22;395(10224):565-74
  3. Bonilla-Aldana DK, Quintero-Rada K, Montoya-Posada JP, et al. SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? A bibliometric analysis. Travel Med Infect Dis 2020;33:101566.doi: 10.1016/j. tmaid.2020.101566 [Crossref] 4. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798):270-3. [Crossref] 5. WHO int. infectional desease statistics. Available from: https:// www.who.int/emergencies/diseases/novel-coronavirus-2019
  4. Worldometers. Available from: https://www.worldometers.info/ coronavirus/
  5. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet 2020;395(10223):507-13. [Crossref] 8. Liang W, Guan W, Chen R, et al. Cancer patients in SARSCoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-7. [Crossref] 9. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol 2020;6:1108-10. [Crossref] 10. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol 2020;31:894-901. [Crossref] 11. Lung Cancer Study Group, Chinese Thoracic Society, Chinese Medical Association; Chinese Respiratory Oncology Collaboration. [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of coronavirus disease 2019 (Trial version)]. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:297-301
  6. Zhao Z, Bai H, Duan JC, Wang J. [Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2020;42:E007
  7. Xu Y, Liu H, Hu K, Wang M. [Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)]. Zhongguo Fei Ai Za Zhi 2020;23:136- 41
  8. Kamboj M, Sepkowitz KA. Nosocomial infection